1. Home
  2. BLTE vs Z Comparison

BLTE vs Z Comparison

Compare BLTE & Z Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$147.72

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Zillow Group Inc. Class C Capital Stock

Z

Zillow Group Inc. Class C Capital Stock

HOLD

Current Price

$32.85

Market Cap

7.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLTE
Z
Founded
2018
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
7.1B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BLTE
Z
Price
$147.72
$32.85
Analyst Decision
Strong Buy
Hold
Analyst Count
9
7
Target Price
★ $228.89
$41.83
AVG Volume (30 Days)
133.0K
★ 4.2M
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 118.75
EPS
N/A
★ 0.18
Revenue
N/A
★ $1,076,794,000.00
Revenue This Year
N/A
$14.05
Revenue Next Year
N/A
$11.60
P/E Ratio
★ N/A
$189.36
Revenue Growth
N/A
★ 27.19
52 Week Low
$90.84
$26.67
52 Week High
$200.00
$78.06

Technical Indicators

Market Signals
Indicator
BLTE
Z
Relative Strength Index (RSI) 39.67 59.37
Support Level $145.21 $29.49
Resistance Level $161.08 $34.46
Average True Range (ATR) 5.89 1.49
MACD -0.37 0.73
Stochastic Oscillator 30.70 77.62

Price Performance

Historical Comparison
BLTE
Z

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About Z Zillow Group Inc. Class C Capital Stock

Zillow Group Inc is a real estate technology company offering a digital platform that connects real estate customers with sellers, agents, loan officers, and other real estate-related professionals. With its tools and resources, Zillow helps real estate professionals grow their businesses, and for renters and housing providers, it offers a marketplace along with a set of end-to-end products and services to streamline applications, leases, payments, and more. The group operates various brands such as Zillow, Zillow Home Loans, Zillow Rentals, Zillow New Construction, Trulia, StreetEasy, Out East, HotPads, Follow Up Boss, ShowingTime, dotloop, and Zillow Closing. Its ecosystem spans the entire home journey from shopping to renting, buying, selling, and financing real estate.

Share on Social Networks: